Skip to main content

Posts

Showing posts from March, 2016

Patient's Prescribed Xarelto May Receive Monetary Compensation

Patient compensation may arise from inadequate warnings The lawsuits that have been filed arise from the common claim that the companies responsible for Xarelto provided inadequate warning of the drugs potentially fatal side effects. The lawsuits claim that another drug, Warafin, which has potentially less severe side effects, would have been prescribed if physicians had been provided adequate warnings concerning Xarelto. How could I receive compensation for taking Xarelto? Xarelto legal compensation is still years away. Compensation would only be available after a comprehensive investigation and the successful litigation of the lawsuits or in the event that a settlement could be reached. In order to be eligible for compensation, a patient, or their survivor, would have to file a lawsuit or join an existing lawsuit against the companies responsible for the drug.

Lawsuits are being filed against the companies responsible for the drug Xarelto

What is Xarelto? The Prescription drug Xarelto is a blood thinner prescribed to help prevent blood clots. Janssen Pharmaceutical is the company that manufactures the blood thinner. Bayer Healthcare co-markets the drug with Janssen. Both have been named in various lawsuits. Why are Janssen and Bayer being sued? The lawsuit arises out of accusations that the companies failed to adequately warn of the risks associated with taking Xarelto. The biggest risk is severe internal bleeding for which there is currently no known cure. Ultimately, a patient could die because of it. The lawsuit claims that adequate warning would have resulted in the drug Warafin being prescribed. Warafin may still cause internal bleeding, but this problem may be treated by giving the patient high doses of Vitamin K. I take Xarelto, what should I do? You should immediately stop participating in any activity that might result in injury, even an injury as innocuous as a bruise or a cut. If, despi...